Current Infectious Disease Reports

, Volume 7, Issue 5, pp 357–358

New antimicrobial agents active against Staphylococcus aureus

Authors

  • James S. Tan
Clinical Trials Report

DOI: 10.1007/s11908-005-0009-x

Cite this article as:
Tan, J.S. Curr Infect Dis Rep (2005) 7: 357. doi:10.1007/s11908-005-0009-x
  • 22 Views

Conclusions

Clinical and microbiologic results of this study support, preliminarily, that telavancin is an effective antimicrobial agent for the treatment of infection due to MRSA.

Copyright information

© Current Science Inc. 2005